Showing results (41-50 of 98) with videos related to
Sort By:
Pageof 10
BMC Research Notes|September 9, 2015
cFinder: definition and quantification of multiple haplotypes in a mixed sampleNorbert Niklas, Julia Hafenscher, Agnes Barna, et al.Journal of Pediatric Hematology/Oncology|October 12, 2005
Antithymocyte globulin pharmacokinetics in pediatric patients after hematopoietic stem cell transplantationMarkus G Seidel, Gerhard Fritsch, Susanne Matthes-Martin, et al.Haematologica|October 13, 2005
In vitro and in vivo T-cell depletion with myeloablative or reduced-intensity conditioning in pediatric hematopoietic stem cell transplantationMarkus G Seidel, Gerhard Fritsch, Susanne Matthes-Martin, et al.Respiratory Research|November 14, 2013
Efficacy of a carrageenan nasal spray in patients with common cold: a randomized controlled trialMartin Ludwig, Elisabeth Enzenhofer, Sven Schneider, et al.BMC Complementary and Alternative Medicine|September 7, 2012
Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common coldTamas Fazekas, Philipp Eickhoff, Nathalie Pruckner, et al.Haematologica|November 21, 2007
Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian childrenLeo Kager, Thomas Lion, Andishe Attarbaschi, et al.Journal of Pediatric Hematology/Oncology|July 7, 2012
Prevalence and clinical course of viral upper respiratory tract infections in immunocompromised pediatric patients with malignancies or after hematopoietic stem cell transplantationTamas Fazekas, Philipp Eickhoff, Margit Rauch, et al.European Journal of Haematology|February 2, 2013
Stem cell transplantation after reduced-intensity conditioning for sickle cell diseaseSusanne Matthes-Martin, Anita Lawitschka, Gerhard Fritsch, et al.Hematological Oncology|August 7, 2020
A phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha-2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia (CML) not achieving a deep molecular response (molecular remission 4.5)-AGMT_CML 1Sonja Heibl, Veronika Buxhofer-Ausch, Stefan Schmidt, et al.International Journal of Molecular Sciences|May 3, 2016
Quantitative Analysis of Mutant Subclones in Chronic Myeloid Leukemia: Comparison of Different Methodological ApproachesSandra Preuner, Agnes Barna, Florian Frommlet, et al.Pageof 10